|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
Statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malvezzi M, Bertuccio P, Levi F, La
Vecchia C and Negri E: European cancer mortality predictions for
the year 2014. Ann Oncol. 25:1650–1656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsukuma H, Ajiki W and Oshima A: Cancer
incidence in Japan. Gan To Kagaku Ryoho. 31:840–846. 2004.(In
Japanese). PubMed/NCBI
|
|
4
|
Koehler A, Bataille F, Schmid C, Ruemmele
P, Waldeck A, Blaszyk H, Hartmann A, Hofstaedter F and Dietmaier W:
Gene expression profiling of colorectal cancer and metastases
divides tumours according to their clinicopathological stage. J
Pathol. 204:65–74. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Croner RS, Foertsch T, Brueckl WM,
Guenther K, Siebenhaar R, Stremmel C, Matzel KE, Papadopoulos T,
Kirchner T, Behrens J, et al: Common denominator genes that
distinguish colorectal carcinoma from normal mucosa. Int J
Colorectal Dis. 20:353–362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raetz EA and Moos PJ: Impact of microarray
technology in clinical oncology. Cancer Invest. 22:312–320. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohmachi T, Tanaka F, Mimori K, Inoue H,
Yanaga K and Mori M: Clinical significance of TROP2 expression in
colorectal cancer. Clin Cancer Res. 12:3057–3063. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bertucci F, Salas S, Eysteries S, Nasser
V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart
L, Montfort J, et al: Gene expression profiling of colon cancer by
DNA microarrays and correlation with histoclinical parameters.
Oncogene. 23:1377–1391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bianchini M, Levy E, Zucchini C, Pinski V,
Macagno C, De Sanctis P, Valvassori L, Carinci P and Mordoh J:
Comparative study of gene expression by cDNA microarray in human
colorectal cancer tissues and normal mucosa. Int J Oncol. 29:83–94.
2006.PubMed/NCBI
|
|
10
|
Birkenkamp-Demtroder K, Christensen LL,
Olesen SH, Frederiksen CM, Laiho P, Aaltonen LA, Laurberg S,
Sørensen FB, Hagemann R and ØRntoft TF: Gene expression in
colorectal cancer. Cancer Res. 62:4352–4363. 2002.PubMed/NCBI
|
|
11
|
Lawlor KG, Telang NT, Osborne MP,
Schaapveld RQ, Cho KR, Vogelstein B and Narayanan R: Antisense RNA
to the putative tumor suppressor gene ‘deleted in colorectal
cancer’ transforms fibroblasts. Ann N Y Acad Sci. 660:283–285.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grigoriadis A, Oliver GR, Tanney A,
Kendrick H, Smalley MJ, Jat P and Neville AM: Identification of
differentially expressed sense and antisense transcript pairs in
breast epithelial tissues. BMC Genomics. 10:3242009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kohno K, Chiba M, Murata S, Pak S, Nagai
K, Yamamoto M, Yanagisawa K, Kobayashi A, Yasue H and Ohkohchi N:
Identification of natural antisense transcripts involved in human
colorectal cancer development. Int J Oncol. 37:1425–1432.
2010.PubMed/NCBI
|
|
15
|
Nagai K, Kohno K, Chiba M, Pak S, Murata
S, Fukunaga K, Kobayashi A, Yasue H and Ohkohchi N: Differential
expression profiles of sense and antisense transcripts between
HCV-associated hepatocellular carcinoma and corresponding
non-cancerous liver tissue. Int J Oncol. 40:1813–1820.
2012.PubMed/NCBI
|
|
16
|
Chiba M, Kimura M and Asari S: Exosomes
secreted from human colorectal cancer cell lines contain mRNAs,
microRNAs and natural antisense RNAs, that can transfer into the
human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep.
28:1551–1558. 2012.PubMed/NCBI
|
|
17
|
Benjamini Y and Hochberg Y: Controling the
false discovery rate: A pratical and powerful approach to multiple
testing. J R Statist Soc. 57:289–300. 1995.
|
|
18
|
Ward JH Jr: Hierarchical grouping to
optimize an objective function. J Am Stat Assoc. 58:236–244. 1963.
View Article : Google Scholar
|
|
19
|
Etzioni R, Urban N, Ramsey S, McIntosh M,
Schwartz S, Reid B, Radich J, Anderson G and Hartwell L: The case
for early detection. Nat Rev Cancer. 3:243–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hundt S, Haug U and Brenner H: Blood
markers for early detection of colorectal cancer: A systematic
review. Cancer Epidemiol Biomarkers Prev. 16:1935–1953. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshigai E, Hara T, Araki Y, Tanaka Y,
Oishi M, Tokuhara K, Kaibori M, Okumura T, Kwon AH and Nishizawa M:
Natural antisense transcript-targeted regulation of inducible
nitric oxide synthase mRNA levels. Nitric Oxide. 30:9–16. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Robb GB, Carson AR, Tai SC, Fish JE, Singh
S, Yamada T, Scherer SW, Nakabayashi K and Marsden PA:
Post-transcriptional regulation of endothelial nitric-oxide
synthase by an overlapping antisense mRNA transcript. J Biol Chem.
279:37982–37996. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Camblong J, Iglesias N, Fickentscher C,
Dieppois G and Stutz F: Antisense RNA stabilization induces
transcriptional gene silencing via histone deacetylation in S.
Cerevisiae. Cell. 131:706–717. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Faghihi MA, Zhang M, Huang J, Modarresi F,
Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G III and
Wahlestedt C: Evidence for natural antisense transcript-mediated
inhibition of microRNA function. Genome Biol. 11:R562010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carrieri C, Cimatti L, Biagioli M, Beugnet
A, Zucchelli S, Fedele S, Pesce E, Ferrer I, Collavin L, Santoro C,
et al: Long non-coding antisense RNA controls Uchl1 translation
through an embedded SINEB2 repeat. Nature. 491:454–457. 2012.
View Article : Google Scholar : PubMed/NCBI
|
